The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 4/15/2021 featuring funding details for Tomorrow Health, Creatively, and much more. This page will be updated throughout the day to reflect any new fundings.
Tomorrow Health — $25M – Series A
Tomorrow Health, the at-home healthcare platform, has raised $25M in Series A funding from investors that include Andreessen Horowitz, BoxGroup, and Obvious Ventures. Founded by Gabriel Flateman (cofounded Casper) and Vijay Kedar in 2018, Tomorrow Health has now raised a total of $32.5M in reported equity funding.
Creatively — $5M – Seed
Creatively, the job platform for creatives, has raised $5M in Seed funding from investors that include Advancit Capital, Link Ventures, and The Tornante Company. Creatively was founded by Joe Indriolo and Stacey Bendet in 2019.
Pico — $6.5M – venture
Pico, the CRM and monetization platform for creators to manage their businesses, has raised $6.5M in venture funding from investors that include Bloomberg Beta, Precursor Ventures, Village Global, Stripe, and Ann Lai. Founded by Jason Bade and Nick Chen in 2016, Pico has now raised a total of $11M in reported equity funding.
YellowHeart — $1.05M – Convertible Note
YellowHeart, the blockchain ticketing platform, has raised $1.05M according to a recent SEC filing. The filing indicates that the total offering is for $1.5M and there were five investors in this close. Live Nation Entertainment led previous rounds for the company. Founded by Josh Katz in 2018, YellowHeart has now raised a total of $4.75M in reported equity funding.
C2i Genomics — $100M – Series B
C2i Genomics, the provider of cloud-based cancer diagnostic services, has raised $100M in Series B funding from investors that include NFX, Casdin Capital, Silver Lake, Section 32, Alexandria Real Estate Equities, LionBird, iGlobe Partners, Driehaus Capital Management, The Mark Foundation for Cancer Research, Duquesne Family Office, and Gordon Asset Management. Founded by Asaf Zviran, Boris Oklander, Dan Landau, and Ezra Sofer in 2019, C2i Genomics has now raised a total of $112M in reported equity funding.
